-
Two independent case-control studies investigating the risk of venous thromboembolism (VTE) in users of oral contraceptives (OC) containing 30 mcg of ethinyl estradiol and a progestin component of either drospirenone or levonorgestrel found that VTE risk was two to three times higher in those using a drospirenone pill.
-
The concept that "term" pregnancy applies to any pregnancy extending past 36 completed weeks has been recently strongly challenged.
-
There are at least six different commonly used chemotherapeutic regimens in practice to treat patients with low-risk gestational trophoblastic neoplasia (GTN) with no consensus or previous formal evaluation as to which may be best.
-
New research indicates that early initiation of antiretroviral treatment in people infected with HIV prevents them from transmitting the virus to their partners.
-
Findings from a new analysis indicate that women pay a higher percentage out of pocket when it comes to oral contraceptive (OC) expenditures.
-
Research indicates that while many young women might initiate vaccination for human papillomavirus (HPV), they do not complete the three-injection course of treatment.
-
-
(Editor's Note: Read the September 2011 edition of Contraceptive Technology Update for the second of our two-part special coverage of long-acting reversible contraceptives. Included in the upcoming issue is an in-depth look at the American College of Obstetricians and Gynecologists' new practice bulletin on the use of long-acting reversible contraceptives. The new recommendations offer guidance in selecting appropriate candidates for such methods and provide tips on managing clinical issues that might arise.)
-
Thumbing through your inbox charts, you see your next patient is a 19-year-old who began use of oral contraceptives (OCs) about six months ago. When you talk with her in the examination room, however, you find that she has discontinued use of the Pill after she began to gain weight.
-
While adolescents are at risk for HIV, many forego testing. This lack of testing is a major public health concern, as more than 50% of HIV-infected adolescents do not know their infection status.
